Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration

The term neurodegeneration with brain iron accumulation (NBIA) brings together a broad set of progressive and disabling neurological genetic disorders in which iron is deposited preferentially in certain areas of the brain. Among NBIA disorders, the most frequent subtype is pantothenate kinase-assoc...

Descripción completa

Detalles Bibliográficos
Autores: Álvarez-Córdoba, Mónica, Talaverón-Rey, Marta, Povea-Cabello, Suleva, Cilleros-Holgado, Paula, Gómez-Fernández, David, Piñero-Perez, Rocío, Reche-López, Diana, Munuera, Manuel, Suárez-Carrillo, Alejandra, Romero-González, Ana, Romero-Domínguez, José Manuel, López-Cabrera, Alejandra, Armengol, José Ángel, Sánchez-Alcázar, José Antonio
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:España
Institución:Consejo Superior de Investigaciones Científicas (CSIC)
Repositorio:DIGITAL.CSIC. Repositorio Institucional del CSIC
OAI Identifier:oai:digital.csic.es:10261/341877
Acceso en línea:http://hdl.handle.net/10261/341877
Access Level:acceso abierto
Palabra clave:Neurodegeneration with brain iron accumulation (NBIA)
Pantothenate kinase-associated neurodegeneration (PKAN)
Pantothenate kinase 2 (PANK2)
Pantothenate
Pantethine
Vitamin E
Omega 3
α-lipoic acid
L-carnitine
Thiamine
Fibroblasts
Induced neurons
Precision medicine
id ES_8316cd8ea2d0b180efdc64c35e274eda
oai_identifier_str oai:digital.csic.es:10261/341877
network_acronym_str ES
network_name_str España
repository_id_str
spelling Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated NeurodegenerationÁlvarez-Córdoba, MónicaTalaverón-Rey, MartaPovea-Cabello, SulevaCilleros-Holgado, PaulaGómez-Fernández, DavidPiñero-Perez, RocíoReche-López, DianaMunuera, ManuelSuárez-Carrillo, AlejandraRomero-González, AnaRomero-Domínguez, José ManuelLópez-Cabrera, AlejandraArmengol, José ÁngelSánchez-Alcázar, José AntonioNeurodegeneration with brain iron accumulation (NBIA)Pantothenate kinase-associated neurodegeneration (PKAN)Pantothenate kinase 2 (PANK2)PantothenatePantethineVitamin EOmega 3α-lipoic acidL-carnitineThiamineFibroblastsInduced neuronsPrecision medicineThe term neurodegeneration with brain iron accumulation (NBIA) brings together a broad set of progressive and disabling neurological genetic disorders in which iron is deposited preferentially in certain areas of the brain. Among NBIA disorders, the most frequent subtype is pantothenate kinase-associated neurodegeneration (PKAN) caused by pathologic variants in the PANK2 gene codifying the enzyme pantothenate kinase 2 (PANK2). To date, there are no effective treatments to stop the progression of these diseases. This review discusses the utility of patient-derived cell models as a valuable tool for the identification of pharmacological or natural compounds for implementing polytarget precision medicine in PKAN. Recently, several studies have described that PKAN patient-derived fibroblasts present the main pathological features associated with the disease including intracellular iron overload. Interestingly, treatment of mutant cell cultures with various supplements such as pantothenate, pantethine, vitamin E, omega 3, α-lipoic acid L-carnitine or thiamine, improved all pathophysiological alterations in PKAN fibroblasts with residual expression of the PANK2 enzyme. The information provided by pharmacological screenings in patient-derived cellular models can help optimize therapeutic strategies in individual PKAN patients.This work was supported by PI19/00377 and PI22/00142 grants, Instituto de Salud Carlos III, Spain and Fondo Europeo de Desarrollo Regional (FEDER-Unión Europea), Proyectos de Investigación de Excelencia de la Junta de Andalucía PY18-850 and UPO-FEDER 2018 (UPO-1380614).Peer reviewedMultidisciplinary Digital Publishing InstituteInstituto de Salud Carlos IIIEuropean CommissionJunta de AndalucíaConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]2024202420232024info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_dcae04bcPublisher's versioninfo:eu-repo/semantics/publishedVersionapplication/pdfhttp://hdl.handle.net/10261/341877reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://dx.doi.org/10.3390/ph16101359Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/3418772026-05-22T06:33:51Z
dc.title.none.fl_str_mv Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
title Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
spellingShingle Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
Álvarez-Córdoba, Mónica
Neurodegeneration with brain iron accumulation (NBIA)
Pantothenate kinase-associated neurodegeneration (PKAN)
Pantothenate kinase 2 (PANK2)
Pantothenate
Pantethine
Vitamin E
Omega 3
α-lipoic acid
L-carnitine
Thiamine
Fibroblasts
Induced neurons
Precision medicine
title_short Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
title_full Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
title_fullStr Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
title_full_unstemmed Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
title_sort Patient-Derived Cellular Models for Polytarget Precision Medicine in Pantothenate Kinase-Associated Neurodegeneration
dc.creator.none.fl_str_mv Álvarez-Córdoba, Mónica
Talaverón-Rey, Marta
Povea-Cabello, Suleva
Cilleros-Holgado, Paula
Gómez-Fernández, David
Piñero-Perez, Rocío
Reche-López, Diana
Munuera, Manuel
Suárez-Carrillo, Alejandra
Romero-González, Ana
Romero-Domínguez, José Manuel
López-Cabrera, Alejandra
Armengol, José Ángel
Sánchez-Alcázar, José Antonio
author Álvarez-Córdoba, Mónica
author_facet Álvarez-Córdoba, Mónica
Talaverón-Rey, Marta
Povea-Cabello, Suleva
Cilleros-Holgado, Paula
Gómez-Fernández, David
Piñero-Perez, Rocío
Reche-López, Diana
Munuera, Manuel
Suárez-Carrillo, Alejandra
Romero-González, Ana
Romero-Domínguez, José Manuel
López-Cabrera, Alejandra
Armengol, José Ángel
Sánchez-Alcázar, José Antonio
author_role author
author2 Talaverón-Rey, Marta
Povea-Cabello, Suleva
Cilleros-Holgado, Paula
Gómez-Fernández, David
Piñero-Perez, Rocío
Reche-López, Diana
Munuera, Manuel
Suárez-Carrillo, Alejandra
Romero-González, Ana
Romero-Domínguez, José Manuel
López-Cabrera, Alejandra
Armengol, José Ángel
Sánchez-Alcázar, José Antonio
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Instituto de Salud Carlos III
European Commission
Junta de Andalucía
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]
dc.subject.none.fl_str_mv Neurodegeneration with brain iron accumulation (NBIA)
Pantothenate kinase-associated neurodegeneration (PKAN)
Pantothenate kinase 2 (PANK2)
Pantothenate
Pantethine
Vitamin E
Omega 3
α-lipoic acid
L-carnitine
Thiamine
Fibroblasts
Induced neurons
Precision medicine
topic Neurodegeneration with brain iron accumulation (NBIA)
Pantothenate kinase-associated neurodegeneration (PKAN)
Pantothenate kinase 2 (PANK2)
Pantothenate
Pantethine
Vitamin E
Omega 3
α-lipoic acid
L-carnitine
Thiamine
Fibroblasts
Induced neurons
Precision medicine
description The term neurodegeneration with brain iron accumulation (NBIA) brings together a broad set of progressive and disabling neurological genetic disorders in which iron is deposited preferentially in certain areas of the brain. Among NBIA disorders, the most frequent subtype is pantothenate kinase-associated neurodegeneration (PKAN) caused by pathologic variants in the PANK2 gene codifying the enzyme pantothenate kinase 2 (PANK2). To date, there are no effective treatments to stop the progression of these diseases. This review discusses the utility of patient-derived cell models as a valuable tool for the identification of pharmacological or natural compounds for implementing polytarget precision medicine in PKAN. Recently, several studies have described that PKAN patient-derived fibroblasts present the main pathological features associated with the disease including intracellular iron overload. Interestingly, treatment of mutant cell cultures with various supplements such as pantothenate, pantethine, vitamin E, omega 3, α-lipoic acid L-carnitine or thiamine, improved all pathophysiological alterations in PKAN fibroblasts with residual expression of the PANK2 enzyme. The information provided by pharmacological screenings in patient-derived cellular models can help optimize therapeutic strategies in individual PKAN patients.
publishDate 2023
dc.date.none.fl_str_mv 2023
2024
2024
2024
dc.type.none.fl_str_mv info:eu-repo/semantics/article
http://purl.org/coar/resource_type/c_dcae04bc
Publisher's version
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10261/341877
url http://hdl.handle.net/10261/341877
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv http://dx.doi.org/10.3390/ph16101359

dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute
publisher.none.fl_str_mv Multidisciplinary Digital Publishing Institute
dc.source.none.fl_str_mv reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC
instname:Consejo Superior de Investigaciones Científicas (CSIC)
instname_str Consejo Superior de Investigaciones Científicas (CSIC)
reponame_str DIGITAL.CSIC. Repositorio Institucional del CSIC
collection DIGITAL.CSIC. Repositorio Institucional del CSIC
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869412108438863873
score 15,811543